Top Markets
Coin of the day
Mustang Bio, Inc. Mustang Bio, Inc.

Mustang Bio, Inc.

MBIO
शेयरों में रैंक #35075
Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on... Mustang Bio, Inc., a clinical-stage biopharmaceutical company, focuses on translating cell therapies into cures for difficult-to-treat cancers and autoimmune diseases in the United States. The company develops MB-106, a CD20-targeted chimeric antigen receptor (CAR) T cell therapy which is in Phase I clinical trail for non-hodgkin lymphoma, chronic lymphocytic leukemia, and autoimmune diseases; MB-109, a combination MB-101 and MB-108 as a potential treatment for IL13Ra2+ relapsed or refractory glioblastoma and high-grade astrocytoma; MB-101, an IL13Ra2 CAR T cell program completd Phase I for glioblastoma; and MB-108 which is in Phase I for the treatment of herpes simplex virus-1 oncolytic virus C134. It has a license agreement with city of hope national medical center and nationwide children’s hospital. Mustang Bio, Inc. was incorporated in 2015 and is headquartered in Waltham, Massachusetts.
शेयर मूल्य
$0.594
अंतिम समन्वयन: 2026-08-14
मार्केट कैप
$4.50M
बदलाव (1 दिन)
0.00%
बदलाव (1 वर्ष)
-66.44%
देश
US
व्यापार Mustang Bio, Inc. (MBIO)

श्रेणी

Mustang Bio, Inc. (MBIO) के लिए स्टॉक मूल्य इतिहास
दिन का सबसे उच्च समापन मूल्य: $0.60 (2026-08-01 को)

दिन का सबसे निम्न समापन मूल्य: $8.92K (2017-08-01 को)
Mustang Bio, Inc. के स्टॉक मूल्य का इतिहास 2017 से 2026 तक
प्रत्येक वर्ष के अंत में स्टॉक मूल्य प्रदर्शन
वर्ष प्रदर्शन
2026 (TTM) -10.26%
2025 -87.55%
2024 -86.83%
2023 -76.52%
2022 -79.00%
2021 -45.05%
2020 -1.99%
2019 18.38%
2018 -73.75%
2017 0.00%
समान कंपनियों या प्रतिस्पर्धियों के स्टॉक मूल्य
कंपनी स्टॉक मूल्य परिवर्तन 1व% देश
$505.24 28.63%
US
$846.09 29.41%
NL
$731.69 6.47%
CH
$1.07K -6.40%
KR
$251.82 11.75%
BE